SMT201400057B - Composizione per il trattamento della fibrosi cistica - Google Patents
Composizione per il trattamento della fibrosi cisticaInfo
- Publication number
- SMT201400057B SMT201400057B SM201400057T SM201400057T SMT201400057B SM T201400057 B SMT201400057 B SM T201400057B SM 201400057 T SM201400057 T SM 201400057T SM 201400057 T SM201400057 T SM 201400057T SM T201400057 B SMT201400057 B SM T201400057B
- Authority
- SM
- San Marino
- Prior art keywords
- treatment
- composition
- cystic fibrosis
- cystic
- fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09167491 | 2009-08-07 | ||
| PCT/EP2010/061428 WO2011015630A1 (en) | 2009-08-07 | 2010-08-05 | Composition for the treatment of cystic fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201400057B true SMT201400057B (it) | 2014-07-07 |
Family
ID=41382119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201400057T SMT201400057B (it) | 2009-08-07 | 2014-04-29 | Composizione per il trattamento della fibrosi cistica |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20120184622A1 (it) |
| EP (1) | EP2461812B1 (it) |
| JP (1) | JP5877787B2 (it) |
| KR (1) | KR101729800B1 (it) |
| CN (1) | CN102548559B (it) |
| AU (1) | AU2010280684B2 (it) |
| BR (1) | BR112012002578B8 (it) |
| CA (1) | CA2770066C (it) |
| CL (1) | CL2012000319A1 (it) |
| CY (1) | CY1114983T1 (it) |
| DK (1) | DK2461812T3 (it) |
| EA (1) | EA023720B1 (it) |
| ES (1) | ES2451790T3 (it) |
| GT (1) | GT201200038A (it) |
| HK (1) | HK1165293A1 (it) |
| HN (1) | HN2012000297A (it) |
| HR (1) | HRP20140277T1 (it) |
| IL (1) | IL217899B (it) |
| PL (1) | PL2461812T3 (it) |
| PT (1) | PT2461812E (it) |
| RS (1) | RS53234B (it) |
| SG (1) | SG178315A1 (it) |
| SI (1) | SI2461812T1 (it) |
| SM (1) | SMT201400057B (it) |
| WO (1) | WO2011015630A1 (it) |
| ZA (1) | ZA201200790B (it) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2764505C (en) | 2009-06-12 | 2018-09-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| BR112013017878B1 (pt) | 2011-01-13 | 2021-08-31 | Scipharm Sàrl | Método para melhorar o enxerto de células-tronco hematopoéticas e composições derivadas |
| SG192677A1 (en) * | 2011-02-07 | 2013-09-30 | Scipharm Sarl | Novel composition for the treatment of cystic fibrosis |
| ES2927844T3 (es) | 2013-01-11 | 2022-11-11 | Corsair Pharma Inc | Profármacos de treprostinil |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
| EA031604B1 (ru) | 2013-10-25 | 2019-01-31 | Инсмед Инкорпорейтед | Трепростинильные соединения, композиции и способы их использования |
| CA2967385C (en) | 2014-11-18 | 2023-05-16 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| AU2017261317A1 (en) | 2016-05-05 | 2018-12-13 | Liquidia Technologies, Inc. | Dry powder treprostinil for the treatment of pulmonary hypertension |
| CA3038276A1 (en) | 2016-09-26 | 2018-03-29 | United Therapeutics Corporation | Treprostinil prodrugs |
| KR20220002600A (ko) | 2019-04-29 | 2022-01-06 | 인스메드 인코포레이티드 | 트레프로스티닐 전구약물의 건조 분말 조성물 및 이의 사용 방법 |
| CN114616225A (zh) | 2019-08-23 | 2022-06-10 | 联合治疗公司 | 曲前列环素前药 |
| AU2021255621A1 (en) | 2020-04-17 | 2022-10-20 | United Therapeutics Corporation | Treprostinil for use in the treatment of intersitial lung disease |
| JP2023529828A (ja) | 2020-06-09 | 2023-07-12 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルのフマリルジケトピペリジンプロドラッグ |
| IL303668A (en) | 2020-12-14 | 2023-08-01 | United Therapeutics Corp | Stable treprostinil prodrugs and their uses for the treatment of diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6310898A (en) * | 1997-03-14 | 1998-10-12 | Toray Industries, Inc. | Sustained-release prostaglandin i derivative preparation |
| AU4976599A (en) * | 1998-07-08 | 2000-02-01 | Fibrogen, Inc. | Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives |
| MXPA04002006A (es) * | 2001-08-31 | 2004-06-07 | Sucampo Ag | Analogos de prostagladina como abridor del canal de cloruro. |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| ES2622471T5 (es) * | 2003-05-22 | 2020-07-23 | United Therapeutics Corp | Compuestos y procedimientos para la administración de análogos de prostaciclina |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| US20080096915A1 (en) * | 2005-01-13 | 2008-04-24 | Greenberg Traurig LLP | Compositions for the treatment of metabolic disorders |
| WO2007050783A2 (en) * | 2005-10-26 | 2007-05-03 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| CN101410119B (zh) * | 2006-02-03 | 2012-03-07 | 埃科特莱茵单一股份公司 | 依前列醇制剂及其制备方法 |
| WO2008098196A1 (en) * | 2007-02-09 | 2008-08-14 | United Therapeutics Corporation | Treprostinil treatment for interstitial lung disease and asthma |
-
2010
- 2010-08-05 JP JP2012523343A patent/JP5877787B2/ja active Active
- 2010-08-05 PL PL10739941T patent/PL2461812T3/pl unknown
- 2010-08-05 EA EA201200253A patent/EA023720B1/ru not_active IP Right Cessation
- 2010-08-05 SI SI201030560T patent/SI2461812T1/sl unknown
- 2010-08-05 EP EP10739941.2A patent/EP2461812B1/en active Active
- 2010-08-05 SG SG2012008702A patent/SG178315A1/en unknown
- 2010-08-05 BR BR112012002578A patent/BR112012002578B8/pt not_active IP Right Cessation
- 2010-08-05 DK DK10739941.2T patent/DK2461812T3/da active
- 2010-08-05 AU AU2010280684A patent/AU2010280684B2/en not_active Ceased
- 2010-08-05 PT PT107399412T patent/PT2461812E/pt unknown
- 2010-08-05 US US13/389,281 patent/US20120184622A1/en not_active Abandoned
- 2010-08-05 RS RS20140134A patent/RS53234B/en unknown
- 2010-08-05 CN CN2010800454199A patent/CN102548559B/zh not_active Expired - Fee Related
- 2010-08-05 ES ES10739941.2T patent/ES2451790T3/es active Active
- 2010-08-05 CA CA2770066A patent/CA2770066C/en not_active Expired - Fee Related
- 2010-08-05 WO PCT/EP2010/061428 patent/WO2011015630A1/en active Application Filing
- 2010-08-05 KR KR1020127003535A patent/KR101729800B1/ko active IP Right Grant
-
2012
- 2012-02-01 ZA ZA2012/00790A patent/ZA201200790B/en unknown
- 2012-02-02 IL IL217899A patent/IL217899B/en active IP Right Grant
- 2012-02-07 HN HN2012000297A patent/HN2012000297A/es unknown
- 2012-02-07 CL CL2012000319A patent/CL2012000319A1/es unknown
- 2012-02-07 GT GT201200038A patent/GT201200038A/es unknown
- 2012-06-20 HK HK12106037.8A patent/HK1165293A1/xx not_active IP Right Cessation
-
2014
- 2014-03-18 CY CY20141100210T patent/CY1114983T1/el unknown
- 2014-03-21 HR HRP20140277AT patent/HRP20140277T1/hr unknown
- 2014-04-29 SM SM201400057T patent/SMT201400057B/it unknown
-
2015
- 2015-12-22 US US14/978,914 patent/US10086001B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201400057B (it) | Composizione per il trattamento della fibrosi cistica | |
| SMT201700099B (it) | Nuova composizione per il trattamento di fibrosi cistica | |
| GB0818074D0 (en) | Treatment of biofilms | |
| GB0921075D0 (en) | Novel combination of the therapeutic agents | |
| EP2231687A4 (en) | NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES | |
| IL210290A0 (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
| IT1395509B1 (it) | Composizione per il trattamento della patologia emorroidaria e delle patologie correlate | |
| EP2184353A4 (en) | TREATMENT OF INFLUENZA | |
| IT1403587B1 (it) | Composizione per il trattamento di disordini metabolici | |
| SMT201500119B (it) | Nuova composizione per il trattamento della trombocitemia essenziale | |
| PL2323625T3 (pl) | Nowa kompozycja do leczenia pigmentacji wybroczynowych | |
| IT1397023B1 (it) | Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva | |
| IT1393338B1 (it) | Uso terapeutico della metadoxina come inibitore della fibrosi epatica. | |
| GB201000499D0 (en) | Treatment of cystic fibrosis | |
| GB0819446D0 (en) | Treatment of inflammatory disorders | |
| IT1399791B1 (it) | Composizioni farmaceutiche per il trattamento della poliposi nasale | |
| TWM370404U (en) | Structure of compound massage set | |
| GB201000571D0 (en) | Treatment of cystic fibrosis | |
| GB0802904D0 (en) | Treatment of metabolic syndrome | |
| UA20620S (uk) | Масажер | |
| SE0801580L (sv) | Massageredskap | |
| GB0804468D0 (en) | Treatment of influenza | |
| FI20085700A0 (fi) | Parannettu hierontalaite | |
| TWM365740U (en) | Massager structure | |
| TWM390140U (en) | Improved structure of walker |